Causes and Types of Cell Death: Necrosis & Apoptosis

Causes and Types of Cell Death

Why cells die • physiologic and pathologic death • accidental and regulated pathways • morphology • inflammation • clinical interpretation

Cell death is the permanent loss of cellular function and structural integrity. It is essential during development and tissue maintenance, but it becomes disease when too many cells die, when the wrong cells die, or when death occurs at the wrong time. Emergency clinicians need to recognise both the cause of death and the mechanism because the causes are often reversible during the tissue-at-risk window even though an established dead cell is not.

This lesson provides the classification framework used before studying necrosis and apoptosis in depth. It deliberately separates what started the injury, how the cell died and what the dead cell looks like in tissue.

Learning outcomes

Define cell death and distinguish it from reversible injury and loss of function.
Classify cell death by purpose (physiologic or pathologic), predictability (accidental or regulated) and morphology.
Explain major causes: hypoxia/ischaemia, physical agents, chemicals, infections, immune injury, nutritional-metabolic disease, genetic disorders and ageing.
Compare apoptosis, necrosis, necroptosis, pyroptosis, ferroptosis, parthanatos, mitochondrial permeability transition-driven death and other regulated pathways.
Explain why necrosis is a morphological pattern whereas many modern death pathways are molecular programmes.
Link death pathways to DAMP release, inflammation, organ failure and emergency treatment.
Use history, examination, laboratory tests, imaging and pathology to infer the most likely cause and type of death.

1. What counts as cell death?

A cell is considered dead when it has irreversibly lost the capacity to maintain homeostasis, restore energy production and preserve the plasma membrane. A transient loss of function, ATP depletion or membrane blebbing may still be reversible. In practice, death is inferred from a combination of biochemical, structural and functional evidence.

Concept	Definition	Clinical example
Reversible injury	Stress impairs function but the cell can recover if the cause is removed.	Transient renal tubular hypoxia during dehydration.
Irreversible injury	Mitochondrial failure and membrane/nuclear damage make recovery impossible.	Prolonged coronary occlusion causing infarct-core necrosis.
Cell death	Permanent loss of cellular function and structural integrity, by accidental destruction or an organised death programme.	Apoptosis of autoreactive lymphocytes; necrosis in a brain infarct.
Organ failure	Loss of enough cells or tissue architecture that an organ can no longer meet physiologic demands.	Acute kidney injury after shock.

Three questions to ask for every dead-cell pattern

What was the initiating cause? (for example, ischaemia, toxin, infection or immune attack)
Which molecular pathway operated? (for example, caspase-dependent apoptosis or iron-dependent ferroptosis)
What is the tissue morphology and inflammatory consequence? (for example, coagulative necrosis with neutrophils)

2. Classification by purpose and setting

2.1 Physiologic cell death

Physiologic death is controlled, proportionate and beneficial. It shapes organs, removes cells that have completed their task and maintains a stable cell population. It is most often apoptosis, although other regulated pathways may contribute in selected tissues.

Physiologic process	Why cells die	Example
Embryologic remodelling	Removes transient structures and sculpts organs.	Separation of fingers and toes; neural development.
Hormone-dependent involution	Loss of trophic stimulation activates an orderly death programme.	Endometrial shedding; post-lactational breast involution.
Immune-cell contraction	Removes excess lymphocytes after an immune response.	Death of activated T cells after clearance of infection.
Cell turnover	Replaces old cells while preserving barriers and tissue function.	Intestinal epithelial cells migrating to the villus tip.
Removal of damaged cells	Prevents propagation of cells carrying dangerous mutations.	Apoptosis after irreparable DNA damage.
Resolution of inflammation	Removes spent neutrophils and limits collateral injury.	Macrophage clearance of apoptotic neutrophils.

2.2 Pathologic cell death

Pathologic death follows an injurious stimulus or an inappropriate activation of a death pathway. It can be focal, as in an infarct, or systemic, as in multi-organ injury during severe shock. The same trigger may cause more than one pathway depending on severity, cell type, oxygen availability and the timing of treatment.

3. Classification by predictability: accidental versus regulated

3.1 Accidental cell death

Accidental cell death (ACD) is an immediate or near-immediate consequence of overwhelming physical, chemical or mechanical injury. The cell is destroyed before a coordinated signalling programme can be mounted. Severe burns, crushing, membrane-solubilising toxins and extreme osmotic injury are examples. ACD usually has necrotic morphology, membrane rupture and inflammation.

3.2 Regulated cell death

Regulated cell death (RCD) depends on genetically encoded signalling and can be modified by inhibitors, gene defects or changes in the cellular environment. RCD is not necessarily “peaceful”: necroptosis, pyroptosis and ferroptosis are regulated yet often lytic and inflammatory. Regulation describes the mechanism, not the clinical severity.

Classification axis	Examples	What it predicts
Physiologic vs pathologic	Developmental apoptosis vs infarction.	Whether death is part of normal maintenance or disease.
Accidental vs regulated	Crush injury vs apoptosis/necroptosis.	Whether a molecular programme can be modulated.
Lytic vs non-lytic morphology	Necrosis/pyroptosis vs apoptosis.	Likelihood of DAMP release and inflammation.
Inflammatory vs immunologically quiet	Pyroptosis vs rapid efferocytosis.	Extent of local and systemic inflammatory response.

4. Causes of cell death

4.1 Hypoxia, ischaemia and loss of oxygen delivery

Hypoxia is insufficient oxygen; ischaemia is reduced blood flow and therefore also limits glucose delivery and waste removal. Ischaemia is usually more damaging than hypoxia alone. Oxidative phosphorylation falls, ATP is depleted, ion pumps fail and cells swell. If the insult persists, mitochondrial permeability transition and membrane rupture produce irreversible death.

Reduced arterial flow: thrombosis, embolus, atherosclerotic occlusion or vasospasm.
Reduced venous drainage: congestion, torsion and strangulation increase tissue pressure and reduce the effective perfusion gradient.
Systemic oxygen-delivery failure: shock, severe anaemia, respiratory failure or carbon-monoxide poisoning.
Microvascular failure: sepsis, disseminated intravascular coagulation and endothelial swelling create patchy tissue hypoxia.

4.2 Physical agents

Agent	Cellular damage	Examples
Heat	Protein denaturation, membrane disruption, dehydration and vascular injury.	Thermal burns, hyperthermia and heat stroke.
Cold	Ice crystals, vasoconstriction, ischaemia and reperfusion injury.	Frostbite and accidental hypothermia.
Mechanical force	Direct membrane and cytoskeletal rupture; crush-related ischaemia.	Trauma, compartment syndrome and blast injury.
Radiation	DNA strand breaks and ROS; rapidly dividing cells are vulnerable.	Radiotherapy, nuclear exposure and excessive ultraviolet light.
Electricity	Thermal burns, arrhythmia, muscle injury and electroporation.	High-voltage injury and lightning.
Pressure/osmotic stress	Membrane and organelle disruption from abrupt pressure or electrolyte shifts.	Decompression injury and severe hypernatremia.

4.3 Chemicals, drugs and toxic metabolites

Chemicals can destroy cells directly or require bioactivation to a toxic metabolite. Some block respiration, others damage membranes, disrupt calcium handling, bind proteins or create ROS.

Mechanism	Representative examples	Result
Respiratory-chain inhibition	Cyanide, hydrogen sulphide.	Oxygen cannot be used despite adequate delivery; rapid ATP failure.
Oxygen transport failure	Carbon monoxide, methaemoglobinaemia.	Functional hypoxia and mitochondrial injury.
Reactive metabolite	Paracetamol overdose (NAPQI), aflatoxin, carbon tetrachloride.	Glutathione depletion, lipid peroxidation and hepatocyte death.
Membrane/ion injury	Detergents, solvents, corrosives, heavy metals.	Membrane leakage, enzyme inhibition and necrosis.
Drug or therapeutic toxicity	Anthracyclines, aminoglycosides, chemotherapeutics, local anaesthetic overdose.	Organelle-specific injury, apoptosis or necrosis depending on dose.

4.4 Infectious organisms and their toxins

Microorganisms kill cells through direct cytolysis, replication-associated injury, toxins, vascular obstruction and immune-mediated damage. A pathogen can also change which death pathway dominates: intracellular bacteria may trigger inflammasomes and pyroptosis, while viruses can induce apoptosis or inhibit apoptosis to prolong replication.

Bacteria: exotoxins, endotoxin, pore-forming toxins, abscess formation and sepsis.
Viruses: cytopathic replication, ER stress, syncytia, immune cytotoxicity and apoptosis.
Fungi: tissue invasion, vascular thrombosis and granulomatous inflammation.
Parasites: direct destruction, obstruction, immune-mediated fibrosis and eosinophil injury.
Prions: protein misfolding, neuronal dysfunction and progressive neuronal loss.

4.5 Immune and inflammatory injury

Immune defences can damage host cells when directed against self, a graft or an infected cell. Antibodies and complement perforate membranes; cytotoxic T cells deliver granzymes and perforin; neutrophils release proteases, ROS and extracellular traps; cytokines alter endothelial and mitochondrial function.

Immune mechanism	Death pattern	Example
Complement-mediated lysis	Membrane pores and lytic necrosis.	Autoimmune haemolysis or antibody-mediated rejection.
Cytotoxic T-cell killing	Granzyme-mediated apoptosis; perforin creates entry pores.	Viral hepatitis and transplant rejection.
Neutrophil collateral injury	ROS/protease damage, NET-associated injury and necrosis.	Severe pneumonia or vasculitis.
Immune-complex vasculitis	Fibrinoid necrosis of vessel walls and downstream ischaemia.	Systemic lupus erythematosus and polyarteritis.

4.6 Nutritional and metabolic disturbances

Glucose deficiency: severe hypoglycaemia deprives brain cells of ATP and can cause selective neuronal death.
Excess nutrient/lipid load: lipotoxicity, ER stress and ROS injure hepatocytes, pancreatic beta cells and cardiomyocytes.
Mineral overload: iron catalyses lipid peroxidation; copper damages proteins and mitochondria.
Electrolyte extremes: rapid shifts in sodium or calcium cause osmotic injury, seizures and membrane dysfunction.
Acid-base disturbance: severe acidosis impairs enzymes, contractility and vascular responsiveness.

4.7 Genetic and protein-folding disorders

Mutations may cause death by loss of an essential protein, toxic gain of function, defective DNA repair, mitochondrial disease or lysosomal storage. Misfolded proteins activate chronic ER stress and apoptosis. A mutation that prevents apoptosis can allow genetically unstable cells to survive and progress toward cancer.

4.8 Ageing and accumulated damage

Ageing cells accumulate DNA mutations, telomere shortening, defective mitochondria, oxidised proteins and impaired autophagy. Senescent cells are metabolically active but permanently growth-arrested; their senescence-associated secretory phenotype can injure neighbours and promote chronic inflammation. Excessive death of stem or parenchymal cells contributes to organ failure.

5. Major types of cell death

5.1 Apoptosis

Apoptosis is an organised, energy-dependent death programme using initiator and executioner caspases. Cells shrink, chromatin condenses, membrane-bound apoptotic bodies form and phagocytes remove them. Intrinsic apoptosis is triggered by mitochondrial outer-membrane permeabilisation; extrinsic apoptosis begins at death receptors such as Fas and TNF receptors.

Usually non-lytic: contents remain enclosed, so inflammation is limited.
Physiologic roles: development, tissue turnover, immune contraction and hormone withdrawal.
Pathologic roles: DNA damage, viral infection, duct obstruction and protein-misfolding disease.

5.2 Necrosis

Necrosis is the morphologic pattern of cell and tissue death characterised by swelling, eosinophilia, nuclear dissolution and membrane rupture. It is commonly caused by ischaemia, toxins and infection and usually releases DAMPs that recruit inflammation. Patterns include coagulative, liquefactive, caseous, fat, fibrinoid and gangrenous necrosis.

5.3 Necroptosis

Necroptosis is regulated, caspase-independent lytic death. Signals from TNF-family receptors, toll-like receptors or viral sensors activate RIPK1/RIPK3 and phosphorylate MLKL. MLKL disrupts the plasma membrane, producing necrosis-like morphology and inflammation. It is relevant when apoptosis is blocked or when innate immune signalling is prominent.

5.4 Pyroptosis

Pyroptosis is an inflammatory lytic death linked to inflammasomes. Caspase-1 or related inflammatory caspases cleave gasdermin proteins, creating membrane pores. IL-1β and IL-18 mature and are released. It helps eliminate infected cells but can worsen sepsis, tissue damage and cytokine-driven shock.

5.5 Ferroptosis

Ferroptosis is an iron-dependent death caused by uncontrolled lipid peroxidation. Depletion of glutathione or loss of GPX4 allows oxidised membrane lipids to accumulate. Mitochondrial injury is prominent, while classic apoptotic nuclear fragmentation is not. It has been implicated in kidney, brain, cardiac and ischaemia-reperfusion injury.

5.6 Mitochondrial permeability transition (MPT)-driven necrosis

When calcium and ROS trigger sustained MPTP opening, mitochondrial potential collapses and ATP production stops. If ATP remains too low for apoptosis, the cell swells and ruptures. This pathway is particularly important in ischaemia-reperfusion and toxic injury.

5.7 Parthanatos

Extensive DNA damage activates PARP-1, causing depletion of NAD⁺ and ATP and release of apoptosis-inducing factor from mitochondria. Parthanatos is caspase-independent and can produce large-scale DNA fragmentation. It has been studied in stroke, excitotoxicity and oxidative injury.

5.8 Lysosome-dependent cell death

Damage to lysosomal membranes releases cathepsins, which can digest cytoplasm or activate apoptotic and necrotic pathways. This mechanism may contribute to toxin injury, oxidative stress, storage diseases and some forms of ischaemia.

5.9 NETosis

Neutrophils can release chromatin webs called neutrophil extracellular traps (NETs) to immobilise microbes. Excessive or dysregulated NET formation injures endothelium, promotes thrombosis and contributes to sepsis, vasculitis and autoimmune disease. “NETosis” is used variably; not every NET-release event is a distinct terminal death programme.

5.10 Entosis and other cell-in-cell deaths

Entosis occurs when one living cell is internalised by another, often during altered adhesion or nutrient stress. The internalised cell may die in a lysosome or escape. It has been described in tumours and may influence genomic instability. The term should not be confused with phagocytosis of an already dead apoptotic cell.

5.11 Autophagy: survival first, death in selected contexts

Autophagy recycles damaged organelles during starvation and is primarily a survival response. Excessive or dysregulated autophagy-associated degradation can accompany cell death, but autophagy itself is not automatically synonymous with death. This distinction prevents over-interpreting autophagic vacuoles on microscopy.

6. Morphologic patterns used in pathology

Pattern	Core morphology	Typical cause/site	Inflammation
Coagulative necrosis	Firm tissue, preserved outlines and eosinophilic ghost cells.	Ischaemic infarcts of heart, kidney or spleen.	Yes, usually after the initial insult.
Liquefactive necrosis	Enzymatic digestion, pus or a liquid cavity.	Brain infarction and bacterial abscess.	Prominent.
Caseous necrosis	Granular, friable, cheese-like debris within granulomas.	Tuberculosis and some fungal infections.	Granulomatous.
Fat necrosis	Destroyed adipocytes, chalky calcium soaps and basophilic deposits.	Pancreatitis or trauma.	Inflammatory, often with fat saponification.
Fibrinoid necrosis	Bright eosinophilic material in damaged vessel walls.	Immune vasculitis or severe hypertension.	Usually present.
Apoptotic bodies	Shrunken, intensely eosinophilic fragments with condensed chromatin and an intact membrane.	Physiologic turnover, DNA injury, viral hepatitis.	Minimal if cleared promptly.

7. Inflammation and immunologic consequences

The inflammatory outcome depends less on the word “death” than on whether intracellular contents escape and whether innate sensors are activated.

DAMPs: extracellular ATP, HMGB1, mitochondrial DNA, uric acid, heat-shock proteins and exposed phospholipids signal tissue damage.
PAMPs: microbial molecules such as lipopolysaccharide, flagellin and viral RNA activate the same pattern-recognition systems during infection.
Efferocytosis: prompt engulfment of apoptotic cells produces anti-inflammatory mediators such as TGF-β and IL-10.
Lytic death: necrosis, pyroptosis and necroptosis release DAMPs, cytokines and sometimes viable microbes, amplifying local and systemic inflammation.
Systemic consequence: widespread lytic death can drive endothelial leak, vasodilation, coagulopathy, shock and multi-organ dysfunction.

8. Clinical diagnosis: infer cause, pathway and extent

8.1 History and examination

Finding	Likely clues
Sudden focal deficit or chest pain	Vascular occlusion, ischaemic necrosis, reperfusion risk.
Exposure history	Toxic or metabolic death; identify timing, dose and antidote options.
Fever, rigors, purpura, altered mentation	Infection, pyroptotic inflammation, sepsis or DIC-related ischaemia.
Trauma, crush, burns, compartment signs	Accidental necrosis plus secondary hypoperfusion and rhabdomyolysis.
Autoimmune symptoms or recent transplant	Immune-mediated cytotoxicity, vasculitis or rejection.
Progressive organ dysfunction	Diffuse microvascular, mitochondrial or inflammatory injury; consider multiple simultaneous pathways.

8.2 Laboratory, imaging and pathology

Tool	What it contributes	Limits
Serial biomarkers	Troponin, CK, AST/ALT, LDH, myoglobin, lactate and creatinine support organ injury and trends.	Most are not pathway-specific; release and clearance depend on timing and organ function.
Blood gas/electrolytes	Shows hypoxia, acidosis, hyperkalaemia, hypoglycaemia and metabolic consequences.	May be abnormal before death, or deceptively normal early.
Imaging	Localises infarction, haemorrhage, obstruction, abscess, oedema or non-viable tissue.	Sensitivity varies by organ and disease stage.
Histology	Distinguishes necrotic architecture, apoptosis, granulomas, vascular injury and inflammatory pattern.	Sampling error and delay can obscure the initiating event.
Special stains/IHC	Cleaved caspase-3, TUNEL, iron stains and pathogen tests support a mechanism.	Markers are context dependent and rarely prove a pathway alone.

9. Emergency management based on cause

Stabilise immediately: airway, breathing, circulation, glucose, temperature, neurological status and exposure safety.
Restore oxygen delivery and perfusion: treat hypoxaemia, shock, severe anaemia and vascular occlusion; relieve torsion or compartment pressure.
Remove the trigger: discontinue toxins, administer evidence-based antidotes, control seizures or hyperthermia and treat infection promptly.
Limit secondary injury: correct potassium, calcium, glucose and acid-base abnormalities; prevent renal injury during rhabdomyolysis; monitor urine output.
Control the source and inflammation: obtain cultures without delaying antibiotics when sepsis is likely, drain abscesses, debride devitalised tissue and seek surgical review.
Reassess for salvage: serial examination, lactate, ECG, biomarkers, perfusion, mental status and imaging identify tissue that remains viable.

Do not confuse mechanism with an available bedside drug

Knowing that pyroptosis, ferroptosis or necroptosis is occurring improves explanation of the disease but does not mean that a pathway-specific inhibitor is routinely available in emergency practice. Stabilisation, reperfusion when indicated, source control, antidotes and organ support remain the time-critical interventions.

10. Applied cases

Case 1: Brain infarction

A patient develops sudden hemiparesis. The cause is vascular occlusion; the threatened penumbra is hypoxic but potentially viable, while the core may progress to necrosis. Rapid reperfusion assessment is more important than waiting for a late biomarker. Brain infarction evolves toward liquefactive necrosis because enzymatic digestion removes the dead tissue.

Case 2: Bacterial sepsis

Fever, hypotension, mottling and rising lactate reflect pathogen-triggered inflammation, endothelial dysfunction and cellular hypoxia. Pyroptosis and necroptosis may contribute to lytic inflammatory death, while apoptosis removes some immune cells. Treat the infection and shock promptly; the bedside priority is to stop the cause and preserve viable organs.

Case 3: Paracetamol overdose

Excess NAPQI depletes hepatic glutathione and causes mitochondrial and membrane injury, leading to hepatocyte necrosis. Early history and a timed drug level guide N-acetylcysteine treatment. AST/ALT may rise after injury has begun; treatment should not wait for dramatic enzyme elevation when criteria for antidote therapy are met.

Case 4: Autoimmune vasculitis

Immune-complex deposition activates complement and neutrophils, causing fibrinoid necrosis of vessel walls and downstream ischaemia. The visible lesion is necrosis, but the initiating cause is immune-mediated vascular injury. Treatment requires urgent specialist assessment, control of inflammation and protection of threatened organs.

11. Comparison table for exams and practice

Feature	Apoptosis	Necrosis	Necroptosis/pyroptosis	Ferroptosis
Regulated?	Yes.	Often accidental morphologic outcome; may be regulated.	Yes.	Yes.
Cell size	Shrinks.	Swells.	Swells.	Variable; mitochondrial injury prominent.
Membrane	Intact until phagocytosis.	Ruptures.	Ruptures through pores/MLKL.	Eventually fails after lipid peroxidation.
Nuclear change	Condensation and fragmentation.	Pyknosis, karyorrhexis, karyolysis.	Often karyolysis and necrotic debris.	No classic caspase-dependent fragmentation.
Inflammation	Minimal.	Prominent.	Prominent.	Context-dependent.
Key molecules	Caspases, BAX/BAK, cytochrome c.	ATP failure, calcium, ROS, lysosomes.	RIPK1/RIPK3/MLKL or inflammasomes/gasdermin.	Iron, lipid peroxidation, glutathione/GPX4.

12. High-yield misconceptions

“Necrosis is always accidental.” Regulated lytic pathways can produce necrosis-like morphology.
“Apoptosis is always harmless.” Excessive apoptosis can cause organ atrophy and neurodegeneration.
“Any autophagy means cell death.” Autophagy is usually a survival and recycling response.
“Cell death is all-or-none for an organ.” Most injured tissues contain a dead core, a threatened border and viable surrounding cells.
“A pathologist can identify the original cause from morphology alone.” Morphology narrows the possibilities; clinical history, stains, cultures and toxicology are often required.
“A normal early test rules out cell death.” Biomarkers and imaging have time-dependent sensitivity.

13. Quick self-test

What three questions should be asked when classifying cell death?
Answer: What caused it, which molecular pathway operated, and what morphology/inflammatory consequence resulted?
How does ischaemia differ from hypoxia?
Answer: Ischaemia reduces blood flow and therefore oxygen, nutrients and waste removal; hypoxia specifically denotes inadequate oxygen.
Name two regulated lytic pathways.
Answer: Necroptosis and pyroptosis; ferroptosis may also end in membrane failure.
Which type of death is associated with iron-dependent lipid peroxidation?
Answer: Ferroptosis.
Why is apoptosis often non-inflammatory?
Answer: The cell fragments while retaining membrane integrity and is rapidly cleared by efferocytosis.
What pathway creates gasdermin pores and releases IL-1β and IL-18?
Answer: Inflammasome-associated pyroptosis.
What is the treatment principle for threatened but viable tissue?
Answer: Restore oxygen delivery/perfusion and remove the cause before irreversible injury progresses.
Why can the same toxin cause apoptosis at one dose and necrosis at a higher dose?
Answer: A moderate insult may leave enough ATP for an organised programme; overwhelming injury causes rapid energy failure and membrane rupture.

14. Take-home summary

Cell death is permanent loss of homeostasis and structural integrity; reversible injury is not death.
Classify each case by purpose, cause, molecular regulation, morphology and inflammatory outcome.
Major causes include hypoxia/ischaemia, physical agents, toxins, infection, immune injury, metabolic disease, genetic disorders and ageing.
Apoptosis is organised and usually quiet; necrosis is lytic and inflammatory; necroptosis, pyroptosis and ferroptosis are regulated but can be inflammatory.
Morphology alone does not prove the initiating cause or molecular pathway.
Emergency care targets the cause and the tissue-at-risk zone: oxygenation, perfusion, reperfusion when indicated, antidotes, antimicrobials, source control and organ support.

Selected references

Educational note: This resource supports study and clinical reasoning. Current local protocols, senior supervision and national guidelines take precedence in patient care.